AMOEBA SAS (ALMIB.PA) Stock Fundamental Analysis

EPA:ALMIB • FR0011051598

1.03 EUR
-0.01 (-1.15%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

0

ALMIB gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. Both the profitability and financial health of ALMIB have multiple concerns. ALMIB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ALMIB has reported negative net income.
  • In the past year ALMIB has reported a negative cash flow from operations.
  • In the past 5 years ALMIB always reported negative net income.
  • ALMIB had a negative operating cash flow in each of the past 5 years.
ALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • ALMIB has a worse Return On Assets (-115.55%) than 94.20% of its industry peers.
Industry RankSector Rank
ROA -115.55%
ROE N/A
ROIC N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMIB.PA Yearly ROA, ROE, ROICALMIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

1.3 Margins

  • ALMIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMIB.PA Yearly Profit, Operating, Gross MarginsALMIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ALMIB has been increased compared to 1 year ago.
  • ALMIB has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALMIB has a worse debt to assets ratio.
ALMIB.PA Yearly Shares OutstandingALMIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALMIB.PA Yearly Total Debt VS Total AssetsALMIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -8.51, we must say that ALMIB is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -8.51, ALMIB is not doing good in the industry: 88.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.51
ROIC/WACCN/A
WACCN/A
ALMIB.PA Yearly LT Debt VS Equity VS FCFALMIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

  • ALMIB has a Current Ratio of 0.28. This is a bad value and indicates that ALMIB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALMIB has a worse Current ratio (0.28) than 94.20% of its industry peers.
  • A Quick Ratio of 0.25 indicates that ALMIB may have some problems paying its short term obligations.
  • ALMIB has a Quick ratio of 0.25. This is amonst the worse of the industry: ALMIB underperforms 94.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.25
ALMIB.PA Yearly Current Assets VS Current LiabilitesALMIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ALMIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.60%, which is quite impressive.
EPS 1Y (TTM)47.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ALMIB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.06% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.86%
EPS Next 2Y3.27%
EPS Next 3Y21.16%
EPS Next 5Y31.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMIB.PA Yearly Revenue VS EstimatesALMIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
ALMIB.PA Yearly EPS VS EstimatesALMIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ALMIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMIB.PA Price Earnings VS Forward Price EarningsALMIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMIB.PA Per share dataALMIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALMIB's earnings are expected to grow with 21.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.27%
EPS Next 3Y21.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALMIB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMOEBA SAS

EPA:ALMIB (2/27/2026, 7:00:00 PM)

1.03

-0.01 (-1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-03
Earnings (Next)03-25
Inst Owners0.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap70.99M
Revenue(TTM)N/A
Net Income(TTM)-7.36M
Analysts85.45
Price Target1.53 (48.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)4.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -115.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 217.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.25
Altman-Z -8.51
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)289.55%
Cap/Depr(5y)177.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.52%
EPS Next Y12.86%
EPS Next 2Y3.27%
EPS Next 3Y21.16%
EPS Next 5Y31.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.68%
EBIT Next 3Y24.86%
EBIT Next 5YN/A
FCF growth 1Y-8.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.26%
OCF growth 3YN/A
OCF growth 5YN/A

AMOEBA SAS / ALMIB.PA FAQ

Can you provide the ChartMill fundamental rating for AMOEBA SAS?

ChartMill assigns a fundamental rating of 0 / 10 to ALMIB.PA.


What is the valuation status of AMOEBA SAS (ALMIB.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to AMOEBA SAS (ALMIB.PA). This can be considered as Overvalued.


What is the profitability of ALMIB stock?

AMOEBA SAS (ALMIB.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for ALMIB stock?

The financial health rating of AMOEBA SAS (ALMIB.PA) is 0 / 10.


What is the earnings growth outlook for AMOEBA SAS?

The Earnings per Share (EPS) of AMOEBA SAS (ALMIB.PA) is expected to grow by 12.86% in the next year.